PF 41(4) Table of Contents Publish date: Jul 1, 2015 PROPOSED IRA Proposed IRA Intro Section USP MONOGRAPHS Methocarbamol (1-Jan-2016) Protamine Sulfate Injection (1-Jan-2016) IN-PROCESS REVISION IPR Introduction GENERAL CHAPTERS <1130> NUCLEIC ACID-BASED TECHNIQUES—APPROACHES FOR DETECTING TRACE NUCLEIC ACIDS (RESIDUAL DNA TESTING) (USP39-NF34 2S) REAGENTS, INDICATORS, AND SOLUTIONS Reagent Specifications Carbon Tetrachloride (USP39-NF34 2S) 4-Hydroxy-4-phenylpiperidine [NEW] (USP39-NF34 2S) Monosodium Glutamate [NEW] (USP39-NF34 2S) 6Z-Retinoic Acid [NEW] (USP39-NF34 2S) Sulfaguanidine [NEW] (USP39-NF34 2S) Chromatographic Columns L## (Tretinoin, Cosmosil Cholesterol) [NEW] (USP39-NF34 2S) REFERENCE TABLES Container Specifications Containers for Dispensing Capsules and Tablets [NEW] (USP39-NF34 2S) Description and Solubility Description and Solubility of USP and NF Articles [NEW] (USP39-NF34 2S) Description and Solubility - C Description and Solubility - F Description and Solubility - M DIETARY SUPPLEMENT MONOGRAPHS Methylcobalamin Tablets [NEW] (USP39-NF34 2S) Northern Schisandra Fruit Dry Extract [NEW] (USP39-NF34 2S) PF 41(4) Table of Contents 1 | Page NF MONOGRAPHS Chlorobutanol (USP39-NF34 2S) Eucalyptus Oil (USP39-NF34 2S) USP MONOGRAPHS Albuterol Sulfate (USP39-NF34 2S) Alprazolam Extended-Release Tablets (USP39-NF34 2S) Alprazolam Orally Disintegrating Tablets (USP39-NF34 2S) Aminobenzoate Potassium (USP39-NF34 2S) Aminobenzoate Potassium Capsules (USP39-NF34 2S) Aminobenzoate Sodium (USP39-NF34 2S) Gamma-Aminobutyric Acid Capsules [NEW] (USP39-NF34 2S) Chlordiazepoxide Hydrochloride for Injection (USP39-NF34 2S) Diatrizoate Sodium (USP39-NF34 2S) Diclofenac Potassium (USP39-NF34 2S) Diclofenac Sodium (USP39-NF34 2S) Doxapram Hydrochloride (USP39-NF34 2S) Doxapram Hydrochloride Injection (USP39-NF34 2S) Doxycycline Hyclate Capsules (USP39-NF34 2S) Doxycycline Hyclate Tablets (USP39-NF34 2S) Multiple Electrolytes Injection Type 1 (USP39-NF34 2S) Multiple Electrolytes Injection Type 2 (USP39-NF34 2S) Multiple Electrolytes and Dextrose Injection Type 1 (USP39-NF34 2S) Multiple Electrolytes and Dextrose Injection Type 2 (USP39-NF34 2S) Multiple Electrolytes and Dextrose Injection Type 3 (USP39-NF34 2S) Multiple Electrolytes and Dextrose Injection Type 4 (USP39-NF34 2S) Multiple Electrolytes and Invert Sugar Injection Type 1 (USP39-NF34 2S) Multiple Electrolytes and Invert Sugar Injection Type 2 (USP39-NF34 2S) Multiple Electrolytes and Invert Sugar Injection Type 3 (USP39-NF34 2S) Febantel [NEW] (USP39-NF34 2S) Iopanoic Acid (USP39-NF34 2S) Iopanoic Acid Tablets (USP39-NF34 2S) Ipodate Sodium (USP39-NF34 2S) Ipodate Sodium Capsules (USP39-NF34 2S) Lisinopril (USP39-NF34 2S) Mangafodipir Trisodium (USP39-NF34 2S) Mangafodipir Trisodium Injection (USP39-NF34 2S) Methotrexate Injection (USP39-NF34 2S) Methotrexate Tablets (USP39-NF34 2S) Methylene Blue (USP39-NF34 2S) Metronidazole Gel (USP39-NF34 2S) PF 41(4) Table of Contents 2 | Page Miconazole Nitrate (USP39-NF34 2S) Octreotide Acetate (USP39-NF34 2S) Oxymorphone Hydrochloride Injection (USP39-NF34 2S) Oxymorphone Hydrochloride Suppositories (USP39-NF34 2S) Oxymorphone Hydrochloride Tablets [NEW] (USP39-NF34 2S) Oxymorphone Hydrochloride Extended-Release Tablets [NEW] (USP39-NF34 2S) Polyethylene Glycol 3350 (USP39-NF34 2S) Potassium Chloride in Dextrose Injection (USP39-NF34 2S) Potassium Chloride in Dextrose and Sodium Chloride Injection (USP39-NF34 2S) Potassium Chloride in Lactated Ringer's and Dextrose Injection (USP39-NF34 2S) Potassium Chloride in Sodium Chloride Injection (USP39-NF34 2S) Promethazine Hydrochloride (USP39-NF34 2S) Promethazine Hydrochloride Injection (USP39-NF34 2S) Promethazine Hydrochloride Tablets (USP39-NF34 2S) Oral Rehydration Salts (USP39-NF34 2S) Ringer's and Dextrose Injection (USP39-NF34 2S) Lactated Ringer's Injection (USP39-NF34 2S) Lactated Ringer's and Dextrose Injection (USP39-NF34 2S) Half-Strength Lactated Ringer's and Dextrose Injection (USP39-NF34 2S) Modified Lactated Ringer's and Dextrose Injection (USP39-NF34 2S) Sodium Nitroprusside (USP39-NF34 2S) Silver Sulfadiazine (USP39-NF34 2S) Teriparatide Injection [NEW] (USP39-NF34 2S) Testosterone (USP39-NF34 2S) Thiotepa for Injection (USP39-NF34 2S) Tinidazole (USP39-NF34 2S) Tretinoin (USP39-NF34 2S) Tretinoin Cream (USP39-NF34 2S) Vinblastine Sulfate for Injection (USP39-NF34 2S) STAGE 4 HARMONIZATION Stage 4 Harmonization STIMULI TO THE REVISION PROCESS STIMULI TO THE REVISION PROCESS A Rational Approach to Cascade Impactor Mensuration in a Good Cascade Impactor Practice Environment Total Parenteral Nutrition: Position of the USP Elemental Impurities Expert Panel PF 41(4) Table of Contents 3 | Page .